Even before the COVID-19 pandemic began, adolescent mental health in the United States was a growing and far-reaching concern.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Research Mental Health Child & Adolescent
Even before the COVID-19 pandemic began, adolescent mental health in the United States was a growing and far-reaching concern.
Community Child & Adolescent Pediatrics
Even before the COVID-19 pandemic began, anxiety disorders were one of the most common mental health concerns among children. Pre-pandemic, health care providers and caregivers could expect a third of children to meet the criteria for anxiety disorders by the time they were through adolescence.
Research Community Child & Adolescent Pediatrics
Care from an allergist is associated with a reduction in total health care costs for U.S. children with peanut allergy, new research finds.
Research Community Awareness Child & Adolescent
In 2020, firearm injuries were the leading cause of death in U.S. children 18 and younger, accounting for 3,230 children’s deaths, according to the Centers for Disease Control.
Research Community COVID-19 Child & Adolescent CU Medicine Today
Responding to concerns over increased screen time for teenagers during the pandemic and the potential negative effects of social media use, CU School of Medicine psychology faculty members Jenna Glover, PhD, Sandra Fritsch, MD, and Merlin Ariefdjohan, PhD, reviewed recent studies on children and digital technology, synthesizing their findings in a paper published this month in the journal Child and Adolescent Psychiatric Clinics of North America.
In Colorado and across the nation, emergency departments at pediatric hospitals are overflowing with kids who need intensive mental health treatment.
A little more than a month after the Olympics wrap up, women triathletes will be heading to the south of France for another competition on the global stage.
In 1961, Yuri Gagarin became the first human in space. With every kilometre he ascended, he pushed the boundaries of human achievement and catalyzed a surge of interest in exploration, research, development – and medical innovation.
Experts debating the pressing issue of how to prioritize patients in the increasingly common scenario of loss of access or insurance coverage for anti-obesity glucagon-like peptide 1 (GLP-1) receptor agonist drugs argued that comorbidities and obesity severity should strongly warrant continued coverage — while offering key strategies for getting and retaining approval from payers.
13001 East 17th Place
Aurora, CO 80045
303.724.5375
© 2024 The Regents of the University of Colorado, a body corporate. All rights reserved.
Accredited by the Higher Learning Commission. All trademarks are registered property of the University. Used by permission only.